By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Microbiome technology firm Second Genome today announced the closing of a Series A financing round that raised $5 million.

The round was co-led by new investors Advanced Technology Ventures and Morgenthaler Ventures, as well as existing investors Wavepoint Ventures, Seraph Group, and individual investors.

The company, which was founded in 2009 as PhyloTech, also said that Mike Carusi of ATV and Jason Lettmann of Morgenthaler have joined its board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.